Literature DB >> 3764306

Fibronectin in polyethylene glycol precipitates: evidence for a role in immune complexes.

J S Coppock, D L Scott, S D Carter, T M Moreland, M W Robinson.   

Abstract

Fibronectin is involved in the opsonic clearance of particulate material. It is present in plasma and synovial fluid and thus might be expected to have a role in the clearance of immune complexes. We have investigated this in a study of polyethylene glycol (PEG) precipitable material from the serum of patients with rheumatoid arthritis, systemic lupus erythematosus, and other connective tissue disorders. Fibronectin is a significant component of PEG precipitates but the amount present is influenced by the method of preparation: more precipitates at 4 degrees C than at 20 degrees C. Fibronectin precipitation by PEG was considered to be related to immune complexes because: there was no direct relationship between serum fibronectin levels and the amount present in PEG precipitates; radiolabelled purified isolated fibronectin did not precipitate in 4% PEG; there was a direct relationship between the amount of fibronectin in PEG precipitates and the amounts of immunoglobulin G, A, and M. These results indicate that fibronectin is involved in immune complexes in rheumatic diseases, though they do not show it has an important biological role in these circumstances.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3764306     DOI: 10.1007/bf00541509

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Preparation and properties of serum and plasma proteins; the separation of purified fibrinogen from fraction I of human plasma.

Authors:  P R MORRISON; J T EDSALL; S G MILLER
Journal:  J Am Chem Soc       Date:  1948-09       Impact factor: 15.419

2.  Affinity of myeloma IgG proteins for fibronectin.

Authors:  A Hautanen; J Keski-Oja
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

3.  Interaction of fibronectin with C1q and its collagen-like fragment (CLF).

Authors:  E J Menzel; J S Smolen; L Liotta; K B Reid
Journal:  FEBS Lett       Date:  1981-06-29       Impact factor: 4.124

4.  Cryoprecipitation of fibrin-fibrinogen complexes induced by the cold-insoluble globulin of plasma.

Authors:  N E Stathakis; M W Mosesson; A B Chen; D K Galanakis
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

5.  Destruction of a major extracellular adhesive glycoprotein (fibronectin) of human fibroblasts by neutral proteases from polymorphonuclear leukocyte granules.

Authors:  J A McDonald; B J Baum; D M Rosenberg; J A Kelman; S C Brin; R G Crystal
Journal:  Lab Invest       Date:  1979-03       Impact factor: 5.662

6.  Fibronectin as an opsonic regulator of monocyte phagocytosis.

Authors:  A W Simpson; B J Boughton
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

7.  Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma as related to reticuloendothelial function.

Authors:  T M Saba; E Jaffe
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

8.  The significance of fibronectin in cryoprecipitation in rheumatoid arthritis and other diseases.

Authors:  D L Scott; T J Almond; S N Naqvi; D J Lea; R Stone; K W Walton
Journal:  J Rheumatol       Date:  1982 Jul-Aug       Impact factor: 4.666

9.  Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.

Authors:  H R Hill; A O Shigeoka; N H Augustine; D Pritchard; J L Lundblad; R S Schwartz
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

10.  Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes.

Authors:  C G Pommier; S Inada; L F Fries; T Takahashi; M M Frank; E J Brown
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

View more
  5 in total

1.  Fibronectin and immune complexes in rheumatic diseases.

Authors:  K E Herbert; J S Coppock; A M Griffiths; A Williams; M W Robinson; D L Scott
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

2.  What proteins are present in polyethylene glycol precipitates from rheumatic sera?

Authors:  M W Robinson; D G Scott; P A Bacon; K W Walton; J S Coppock; D L Scott
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

3.  Plasma levels of fibronectin in polymyalgia rheumatica giant cell arteritis.

Authors:  L Puccetti; G Marotta; E Remorini; A Lucchetti; M Zuccotti; G Petrini; U Baicchi; M L Ciompi
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

Review 4.  Kawasaki Disease: The Role of Immune Complexes Revisited.

Authors:  Stephanie Menikou; Paul R Langford; Michael Levin
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

5.  A proteomics-based method for identifying antigens within immune complexes.

Authors:  Stephanie Menikou; Andrew J McArdle; Ming-Shi Li; Myrsini Kaforou; Paul R Langford; Michael Levin
Journal:  PLoS One       Date:  2020-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.